KBIO COMPANY Inc. announces capital increase
케이바이오랩스
038530
Signal Score
Historical Avg Return (5d)
+0.26%
Data Coverage
100%n=2473
Risk-adjusted indicator based on 2473 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Event Date: July 6, 2026
AI Analysis Summary
KBIO COMPANY Inc. has announced a decision for a paid-in capital increase, as detailed in a Material Fact Report dated July 6, 2026. The specific terms, including the number of new shares, issuance price, and total funding amount, are not yet determined. The purpose of the capital increase is also not finalized, with potential uses including facility funds, operating funds, or debt repayment. All common shares issued through this capital increase will be subject to a one-year lock-up period from the registration date. The lack of specific financial figures makes it difficult to assess the immediate impact, but the company states the schedule and content may change.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.